Αναζήτηση | Scenario.press

σε πρόσθεσε στο Health

2025-12-10 09:38:22 -

Mapping the Competitive Environment and Strategic Engagements of the Imatinib Drug Market Top Companies Following Patent Expiry

The competitive landscape of the Imatinib Drug Market is sharply bifurcated between the original innovator company and the multitude of generic manufacturers that entered post-patent expiry. Novartis AG, the originator and brand holder (Gleevec/Glivec), continues to maintain a significant presence, capitalizing on brand loyalty, historical market penetration, and premium pricing in specific...

0 Σχόλια 0 Μοιράστηκε 91 Views